In addition, we recently reported that the chromatin reader protein BRD4 promotes cetuximab resistance in HNSCC cell line models, including the PE/CA-PJ49 CtxR cells used in this study [30]. Here, BRD4 is linked to head and neck squamous cell carcinoma.